What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing disease

Published:2011-06-15 Issue:5 Volume:5 Page:393-410
ISSN:1753-0059
Container-title:Expert Opinion on Medical Diagnostics
language:en
Short-container-title:Expert Opinion on Medical Diagnostics

Author:

Kuhle Jens,Petzold Axel

Publisher

Informa Healthcare

Subject

Biochemistry, medical,Molecular Medicine,Biomedical Engineering,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/17530059.2011.592184

Reference260 articles.

1. What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 1: acute and monophasic diseases

2. Biomarkers in Multiple Sclerosis

3. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2004*

4. The epidemiology of multiple sclerosis in Europe

5. Secondary progressive multiple sclerosis: current knowledge and future challenges

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurodegeneration and Multiple Sclerosis;Neurodegenerative Diseases;2018

2. Biomarkers of Disease Progression;Progressive Multiple Sclerosis;2017-08-11

3. Neurodegeneration and Multiple Sclerosis;Neurodegenerative Diseases;2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3